Clinical Supply Management Articles

  1. When Clinical Supply Becomes A Clinical Decision 8/21/2026

    When clinical supply reveals a constraint, someone must decide what it means for patients and data. Strong governance turns those signals into accountable action.

  2. When Communication Fails, Clinical Supply Risk Grows 8/19/2026

    Communication failures often create bigger risks than logistics disruptions. Learn why early visibility and escalation keep clinical supply chains on track.

  3. When IRT Configuration Decisions Disrupt Clinical Supply 8/17/2026

    IRT decisions can make or break clinical supply. Craig Mooney explains how configuration, enrollment, inventory, and human oversight shape trial execution.

  4. Fixing The Data Problem Before AI Can Help Clinical Trial Supply 8/14/2026

    AI cannot fix clinical trial supply forecasting when the underlying data is fragmented. Structuring enrollment, inventory, and label data comes first.

  5. The Shipment Arrived. The Inventory Didn't: Understanding The Hidden Data Dependencies Behind Depot-To-Site Deliveries 8/13/2026

    A shipment can arrive on time yet remain invisible to the systems that drive resupply. Discover how hidden data dependencies can create inventory problems where none exist.

  6. Building Stronger Sponsor–Vendor Relationships 8/12/2026

    Strong sponsor-vendor partnerships are built on trust, transparency, and shared goals. Learn how better communication helps teams reduce risk and keep trials on track.

  7. Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next 8/10/2026

    Having previously explained why early-stage biotechs should avoid overbuilding, Alicia Collins, of Tune Therapeutics, continues the discussion here in part 2, with thoughts on scaling clinical supply, selecting partners, and preparing for future constraints.

  8. How AI Can Improve Clinical Supply Chain Visibility 8/5/2026

    AI can help clinical supply teams identify risks earlier, improve forecasting, and make faster, more informed decisions before disruptions affect trial continuity.

  9. The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon. 8/3/2026

    Early-stage biotechs often overbuild systems too soon. Alicia Collins, of Tune Therapeutics, explains why flexibility, simple processes, and realistic assumptions matter most.

  10. Study Start-Up Is Where Clinical Supply Risk Is Actually Decided 8/3/2026

    Clinical supply risk begins long before the first shipment. Learn how study start-up decisions shape forecasting, inventory, manufacturing, and trial execution.